Skip to content
S66Senate2023-2024 SessionSame asA1262

Let Psychologists Prescribe Medication

Official title

“Relates to collaborative prescriptive authority for psychologists”

Sponsor Pete HarckhamSD-40+1 co-sponsorAffects Education
Status
In Senate Committee
Higher Education
Impact
8/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Higher Education

What's happening

This bill allows qualified psychologists in New York to prescribe certain medications through a new certification process and collaborative agreements.

Why it matters

  1. Expands access to psychiatric care. By allowing specially trained psychologists to prescribe psychotropic medications, the bill could help address shortages of psychiatric prescribers in New York, especially in underserved or rural areas where psychiatrists are scarce.

  2. Imposes rigorous training and safeguards. Psychologists must earn a master's in clinical psychopharmacology, complete at least 400 hours of supervised clinical training with at least 100 patients, and pass a national exam. This extensive preparation is designed to ensure patient safety and competence in prescribing.

  3. Requires ongoing collaboration with medical professionals. Even after certification, psychologists must maintain collaborative relationships with physicians, nurse practitioners, or clinical nurse specialists. This team-based approach aims to ensure medical oversight and comprehensive patient care.

  4. Establishes accountability and oversight. The bill mandates continuing education, malpractice insurance, and regular reporting to state authorities. It also grants the Department of Education the power to revoke, suspend, or require remediation for prescribing psychologists who fall short of standards, prioritizing public health and safety.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Let Psychologists Prescribe Medication

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Pete Harckham

Senator · Senate District 40

Chair, Environmental Conservation

1 Co-sponsor

History

  1. Referred to higher education
  2. Print number 66a
  3. Amend (t) and recommit to higher education
  4. Referred to higher education

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A1262Assembly

Let Psychologists Prescribe Medicine

In Assembly Committee · Higher Education · Sponsor John T. McDonald III

Impact 8 · Significant0% to pass

Full text

6 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

66--A

2023-2024 Regular Sessions

IN SENATE (Prefiled)

January 4, 2023

Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Higher Education -committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee

AN ACT to amend the education law, in relation to collaborative prescriptive authority for psychologists

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The education law is amended by adding a new section 7601-b to read as follows:

§ 7601-b. Collaborative prescriptive authority for psychologists. 1. As used in this section, the following terms shall have the following meanings:

a. "Prescribing psychologist" means any psychologist licensed pursuant to this article who has undergone specialized education and training in preparation for prescriptive practice and who has passed an examination accepted by the department relevant to establishing competence for prescribing, and who has received from the department a certificate of prescriptive authority, which has not been revoked or suspended.

b. "Prescriptive authority" means the authority to prescribe, administer, discontinue and/or distribute without charge, drugs or controlled substances recognized in or customarily used in the diagnosis, treatment and management of individuals with psychiatric, mental, cognitive, nervous, emotional or behavioral disorders, or other procedures directly related thereto within the scope of practice of psychology in accordance with rules and regulations adopted by the department. Prescriptive authority includes ordering and obtaining necessary laboratory tests, procedures, and diagnostic examinations.

c. "Controlled substance" means any drug substance or immediate precursor enumerated in schedules 1-5 of the United States Drug Enforce-

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD01461-03-3

ment Administration Controlled Substance Act and as provided for in article thirty-three of the public health law.

d. "Conditional prescribing certification" means a two-year clinical prescribing fellowship period to obtain clinical experience sufficient to attain competency in the psychopharmacological treatment of a diverse patient population utilizing a collaborative relationship with a collaborating clinician and shall include no less than four hundred hours of clinical training seeing at least one hundred individual patients during such time period.

e. "Prescription" is an order for a drug, laboratory test, or any medicine, device or treatment, including controlled substances, such terms as defined in article one hundred thirty-seven of this title.

f. "Psychotropic medication" means drugs or controlled substances that are recognized as customarily used in the diagnosis, treatment, and management of individuals with psychiatric, mental, cognitive, nervous, substance use disorders, emotional or behavioral disorders. Under this section, psychotropic medication does not include narcotics.

g. "Collaborating clinician" means a licensed physician, osteopathic physician, nurse practitioner, psychiatric nurse practitioner or clinical nurse specialist engaged in a collaborative agreement with a psychologist in the prescribing of psychotropic medication.

2. a. A psychologist licensed under this article may apply to the department for conditional prescribing certification if the psychologist meets the following requirements:

(1) A current license to practice psychology at the doctoral level in this state;

(2) A master's degree in clinical psychopharmacology awarded by a program in a regionally accredited institution of higher education approved by the United States Department of Education as further described in paragraph b of this subdivision;

(3) Successful completion of clinical practicum training in physical assessment and pathophysiology of no less than eighty hours by a health care provider licensed to conduct independent physical assessments;

(4) A passing score on an examination developed by a nationally recognized body, and approved by the department;

(5) Possesses malpractice insurance that will cover the applicant during the period the conditional prescribing certificate is in effect; and

(6) Meets all other requirements, as determined by rules adopted by the department.

b. The necessary prerequisites for the education program shall be determined by the institution that offers such masters level degrees and, in the institution's judgment, shall include sufficient biomedical education to ensure the necessary knowledge and skills to prescribe psychotropic medications in a safe and effective manner. The program shall satisfy the designation requirements of the American Psychological Association for clinical psychopharmacology education and training programs. The program must be established and administered by biomedically trained educators and must demonstrate that all content is covered and that students achieve clinical competency in all areas, and shall include at a minimum:

(1) Science prerequisites, including human anatomy and human physiology, and a course in biology;

(2) Basic science, including human anatomy, human physiology, biochemistry, and genetics;

(3) Functional neuroscience, including neuroanatomy, neurophysiology, and neurochemistry;

(4) Physical examinations, including the measurement and interpretation of vital signs and neurological, cardiovascular, respiratory, abdominal, eye, ear, nose, throat, gastrointestinal, genitourinary, integumentary, allergic and immunologic, and musculoskeletal examinations;

(5) Interpretation of laboratory tests, including therapeutic drug monitoring, blood and urine tests, radiology, electrocardiogram, brain electrophysiology, neuroimaging techniques, and applied genetics;

(6) Pathological basis of disease, including pathophysiology of common clinical cardiovascular, respiratory, gastrointestinal, hepatic, neurological, and endocrine conditions;

(7) Clinical medicine, including clinical manifestations, differential diagnosis, and laboratory or radiological evaluation of commonly encountered medical conditions, including patients with complex medical needs and comorbidities, and medical emergencies and their management;

(8) Clinical neurotherapeutics, including electrophysiology, electroconvulsive therapy and noninvasive interventions, including transcranial magnetic stimulation, neurofeedback, and biofeedback;

(9) Systems of care, including coordination of care with other medical specialties, consultations and referrals, and coordination and consultation in long-term care;

(10) Pharmacology, including pharmacokinetics and drug delivery systems, pharmacodynamics, neuropharmacology, toxicology, and mechanisms of medication interactions;

(11) Clinical pharmacology, including major drug classes and nutritional supplements;

(12) Psychopharmacology, including sedatives and hypnotics, antidepressants, antipsychotics, mood stabilizers, anxiolytics, stimulants, medications for drug dependence, medications for drug adverse effects, pediatric psychopharmacology, geriatric psychopharmacology, including medications for cognitive impairment and polypharmacy, issues of diversity and cultural competence in pharmacological practice, clinical decision making and standard practice guidelines, and guidelines for prescribing controlled substances;

(13) Psychopharmacology research, including phases of drug development, clinical trials in psychiatry, and critical evaluation of evidence; and

(14) Professional, ethical, and legal issues, including conflicts of interest and relationships with the industry, scope of practice issues, diversity and equity issues related to treatment access and adherence and documentation, including nomenclature, abbreviations, and prescription writing.

c. The department may waive certain requirements of paragraph b of this subdivision for applicants who have obtained relevant training and experience including psychologists who are dually licensed as physicians, nurse practitioners, or other health professionals with comparable prescriptive authority in this state.

d. A conditional prescribing certification shall be valid for a period of two years, at the end of which the holder may re-apply pursuant to the requirements of paragraph a of this subdivision. A psychologist with a conditional prescription certification may prescribe psychotropic medications but only when maintaining an ongoing collaborative relationship with a qualified clinician who oversees the patient's general medical care to ensure that necessary medical examinations are conducted, the psychotropic medication is appropriate for the patient's medical condition and significant changes in the patient's medical or psychological condition are discussed, and subject to the following conditions:

(1) the psychologist shall continue to hold a current license to practice psychology in New York and continue to maintain malpractice insurance;

(2) the psychologist shall notify the department of the name of the psychologist's collaborating clinician; and

(3) the collaborating clinician shall notify the clinician's own licensing board of the name of each psychologist utilizing a collaborative agreement with the collaborating clinician.

e. The ongoing collaborative relationship shall be maintained pursuant to guidelines developed by the department and the state board for psychology, which shall optimize patient care.

f. The guidelines shall ensure that the prescribing psychologist or the psychologist with a conditional prescribing certification and the collaborating clinician coordinate, and collaborate on, the care of the patient to provide optimal care. Nothing in this paragraph shall require a prescribing psychologist or psychologist with a conditional prescribing certification to give prior notice to or obtain prior approval from a collaborating clinician to prescribe psychotropic medication to a patient with whom the prescribing psychologist has established a psychologist-patient relationship; provided that the psychologist provides written notice of the prescription to the collaborating clinician within twenty-four hours of its issuance to such patient.

g. A collaborating clinician shall not be liable for the acts of a psychologist with whom there is a collaborative relationship unless the injury or loss arises from those acts under the direction and control of the collaborating clinician.

3. a. A psychologist licensed under this article may apply for a certificate of prescriptive authority, and the department shall issue such prescriptive authority certification, if the applicant meets the following requirements:

(1) Possesses a conditional prescribing certification and has successfully completed two years of prescribing psychotropic medication under such certification. An applicant for a prescription certificate who specializes in the psychological care of children, elderly persons, or persons with comorbid psychological conditions shall complete at least one year prescribing psychotropic medications to such populations under such conditional prescribing certification;

(2) Holds a current license to practice psychology in this state;

(3) Possesses malpractice insurance that will cover the applicant as a prescribing psychologist; and

(4) Meets all other requirements, as determined by rules adopted by the board, for obtaining a certificate of prescriptive authority.

b. A prescribing psychologist may prescribe psychotropic medication pursuant to the provisions of this title subject to the following conditions:

(1) Continues to hold a current license to practice psychology in this state, maintains a prescriptive authority certification issued by the department, and maintains malpractice insurance;

(2) Annually satisfies the continuing education requirements for prescribing psychologists, as determined by the department, which shall be no fewer than twenty-five hours each year; and

(3) Complies with any other rules adopted by the department.

c. The department may grant prescriptive authority certification to an applicant who has a current and unrestricted license to practice psychology and a current and unrestricted certification of prescriptive authority from another state, or training from the United States Department of Defense demonstration project or other similar program developed and operated by any branch of the armed forces that imposes substantially equivalent educational and training requirements as those contained in this chapter and required by the department.

4. a. The department shall prescribe by rule a method for the renewal of prescriptive authority at the time of or in conjunction with the renewal of licenses issued pursuant to this article.

b. Each applicant for renewal of prescriptive authority shall present satisfactory evidence to the department demonstrating the completion of twenty-five hours of continuing education instruction relevant to prescriptive authority during the licensure renewal period.

5. a. Prescribing psychologists shall be authorized to prescribe, administer, discontinue or distribute without charge, drugs or controlled substances recognized in or customarily used in the diagnosis, treatment and management of individuals with psychiatric, mental, cognitive, nervous, emotional or behavioral disorders and relevant to the practice of psychology, or other procedures directly related thereto within the scope of practice of psychology in accordance with rules and regulations adopted by the department.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the education law, in relation to collaborative pres- criptive authority for psychologists

Purpose

To enhance mental health care by providing for prescriptive authority of psychotropic medications to licensed psychologists that complete appro- priate post-licensure education and training.

Summary of provisions

Section 1: Adds a new section § 7601-b to the education law outlining the additional educational, training, and clinical requirements for licensed psychologists to qualify for certification requirements for licensed psychologists to obtain conditional prescribing certifications and a certificate of prescriptive authority. The section also sets out the duties of prescribing psychologists and the responsibilities of the State Education Department related thereto.

Section 2: Amends § 7602 of the education law to require representation of prescribing psychologists on the State Board for Psychology.

Section 3: Amends § 7606 of the education law related to exempting prescribing psychologists from the existing statutory prohibitions on prescribing medications that is applicable to psychologists.

Section 4. Provides an effective date of the first of January next succeeding the date on which it shall have become a law. Effective imme- diately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized and directed to be made and completed on or before such effective date.

Justification

Doctor shortages and lack of care options have created a very dangerous mental healthcare crisis in New York State. With resources stretched to the limit, psychiatrists and other prescribing mental health profes- sionals are in short supply and the demand far exceeds the capabilities of the existing network. This short supply is present in all communities but significantly in our lower economic communities that are medical deserts. Under this legislation, prescribing psychologists will work collaboratively with their patients as well as other healthcare provid- ers in the community. They will conduct a thorough review of a patient's history and symptom presentation. If they determine that psychotropic medication may be appropriate for treatment, they will prescribe that medication but may also recommend a combination of psychotherapy and pharmacotherapy.

Overwhelmingly, primary care physicians report working with prescribing psychologists to be of great benefit to them in other states. It is of note that United States military and civilian psychologists who are currently permitted to prescribe, have written hundreds of thousands of prescriptions without a single complaint or malpractice case in 20 years of work. Prescribing psychologists are dedicated to the highest profes- sional standards. They spend four times as many didactic hours on the study Clinical Psychopharmacology than primary care physicians. The prescriptive authority of psychologists is limited to the medications that treat mental illnesses and the behavioral disorders. The history of prescribing psychologists is that they prescribe 60-70% fewer medica- tions than other health prescribers. Moreover, they will be more likely, than other health prescribers, to "unprescribe" medications because they may consider alternative behavioral therapeutic strategies that can be more effective than medications in some situations, thus reducing side effect complications. Qualified prescribing psychologists are prescrib- ing in New Mexico, Louisiana, Illinois, Iowa, as well as in the US Mili- tary and the Indian Health Service.

Prior legislative history

2014: S.7488

2015-2016: A.9236/S.5824

2017-2018: A.2851/S.4498

2019-2020: A.6132

2021-2022: A.3205

Fiscal implications for state and local governments

None

Effective date

This act shall take effect on the first of January next succeeding the date on which it shall have become a law.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.